| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/16/2006 | US7045609 Hybrid oligonucleotide phosphorothioates |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045598 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045595 For development of therapeutic drugs for diseases associated with immunity or hematopoiesis |
| 05/16/2006 | US7045594 Serine proteinase inhibitors |
| 05/16/2006 | US7045593 Using detergents; antiagglomerants; eukaryotic membrane protein |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045497 Use of peptide |
| 05/16/2006 | US7045363 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles |
| 05/16/2006 | US7045357 Efficiency agrobacterium-mediated plant transformation method |
| 05/16/2006 | US7045356 polyelectrolyte complexes condensed and crosslinked with macromolecules such as polymers, nucleic acids, proteins or drugs; used to deliver biologically active compounds to a cell |
| 05/16/2006 | US7045355 Genes encoding plant transcription factors |
| 05/16/2006 | US7045354 Semicontinuous culture of plant cells in a nutrient medium;monitoring the pH of the medium to monitor expression of an expression product encoded by a polynucleotide under the control of an inducible promoter; antitrypsin |
| 05/16/2006 | US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
| 05/16/2006 | US7045352 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity |
| 05/16/2006 | US7045351 Comprises protein with mitogenic/dual oxidase activity for stimulating production of oxygen intermediates such as superoxide; drug screening |
| 05/16/2006 | US7045348 for gene transfer to dendritic cells; for immunotherapy; chimeras; genetic engineering; contains a fiber protein modified by insertion of a first zipper peptide that can crosslink to a fusion protein and a target ligand |
| 05/16/2006 | US7045347 Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045344 Adenoviral vector and methods for making and using the same |
| 05/16/2006 | US7045338 Temperature sensitive mutant derivatives of the broad host range plasmid pBHR1 |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045334 Nucleotide sequence encoding a benzaldehyde lyase, and process for stereoselectively synthesizing 2-hydroxyketones |
| 05/16/2006 | US7045332 BGL4 β-glucosidase and nucleic acids encoding the same |
| 05/16/2006 | US7045331 EGVII endoglucanase and nucleic acids encoding the same |
| 05/16/2006 | US7045330 DNA sequence of the enzyme phospholipase A1 of ciliate tetrahymena, and the use of the same |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045328 multifunctional enzyme useful in nucleic acid synthesis by primer extension and functioning effectively in polymerase chain reactions (PCR); host cells |
| 05/16/2006 | US7045327 Isolation polypeptides |
| 05/16/2006 | US7045325 32142, 21481, 25964, 21686, novel dehydrogenase molecules and uses therefor |
| 05/16/2006 | US7045324 Tocopherol associated protein (TAP-38) DNA/protein with a 76 nucleotide base deletion resulting in a 25 amino acid deletion, followed by 90 novel nucleotides that code for 30 novel amino acids that are not expressed by TAP-46. The |
| 05/16/2006 | US7045320 Methods for producing L-amino acids |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045317 Bardet-biedl susceptibility gene and uses thereof |
| 05/16/2006 | US7045316 Nucleotide sequences coding transport protein for use in the transfer of drugs in cells |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045313 plasmid containing multiple restriction endonuclease sites comprising a ploypeptide foreign to the vaccina virus or other poxvirus, a virus promoter sequence and a DNA segment from a nonessential regin of the vaccina genome; for expression of the foreign gene after cell or animal infection |
| 05/16/2006 | US7045308 Modulators of leukocyte activation, compositions and methods of use |
| 05/16/2006 | US7045306 assay comprising transcriptional and cognate activators with Huntington's disease mutant protein; linked to detectable sequence within neuron; for preventing or treating a neurodegenerative disease associated with an expanded polyglutamine tract |
| 05/16/2006 | US7045305 targeting probes in living microorganisms or cells by expressing Golgi membrane polypeptide comprising single chain antibody binding ligand that is contacted with a probe/ligand conjugate; detection by fluorescent cell sorting, nuclear magnetic resonance and positron emission tomography |
| 05/16/2006 | US7045304 Contacting a first cell with the compound, determining a first value of a property of the first cell, contacting second cell containing zinc finger protein which modulates expression of the molecular target, determining second value of the cell |
| 05/16/2006 | US7045303 cell-based assays designed to identify compounds that regulate the activity of polycystin; increased adherence to type I collagen coated surfaces; apical expression of NaK-ATPase on the cell membrane |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045298 Method for identifying or screening agonist and antagonist to PPAR |
| 05/16/2006 | US7045295 Method for collecting purified cells |
| 05/16/2006 | US7045293 Alteration of sequence of a target molecule |
| 05/16/2006 | US7045290 Prevention protein misfolding; central nervous system disorders; Alzheimer's, Parkinson's, Huntington's disease therapy |
| 05/16/2006 | US7045284 Reducing translation of Rna virus; genetic engineered nucleic acids |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045136 Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045127 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2006 | US7045126 Genetic engineering; isolation polypeptides; heterogeneity amino acid sequences |
| 05/16/2006 | US7045123 DNA encoding Pseudomonas syringae hypersensitive response elicitor and its use |
| 05/16/2006 | US7045122 Salmonella vaccine |
| 05/16/2006 | CA2260296C Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 05/16/2006 | CA2147468C Method for producing polypeptide via bacterial fermentation |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/15/2006 | CA2502546A1 Sweet potato sporamin gene promoter |
| 05/11/2006 | WO2006050379A2 Modulation of serotonin neurons involving the pet-1 transcriptional control region |
| 05/11/2006 | WO2006050313A2 Protection against herbivores |
| 05/11/2006 | WO2006050038A2 Vesicle trafficking stress-related polypeptides and methods of use in plants |
| 05/11/2006 | WO2006049440A1 Method for producing epidermal growth factor using fusion proteins comprising f a s-1 domain |
| 05/11/2006 | WO2006049315A1 Lignan glycosidase and utilization of the same |
| 05/11/2006 | WO2006049297A1 Novel nucleoside or nucleotide derivative and use thereof |
| 05/11/2006 | WO2006049061A1 Method of detecting h5 or h7 avian influenza virus |
| 05/11/2006 | WO2006049041A1 Bioassay equipment and bioassay method |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 05/11/2006 | WO2006048662A1 Pseudotyped baculovirus and its use |
| 05/11/2006 | WO2006048658A1 Baculovirus-based gene libraries |
| 05/11/2006 | WO2006048467A2 Animal models comprising at least one transgene and one sequence enabling the controlled expression of an rna interfering with this transgene |
| 05/11/2006 | WO2006048466A2 Animal models comprising at least one conditional ko and one conditional ki |
| 05/11/2006 | WO2006048465A2 Animal models comprising at least one mutation or one conditional ki and one conditional ko |
| 05/11/2006 | WO2006048464A2 Expressing heterologous genes in a specific manner in certain tissues of transgenic animal models |
| 05/11/2006 | WO2006048459A2 Selection of host cells expressing protein at high levels |
| 05/11/2006 | WO2006048252A1 Multifunctional and multivalent angiogenesis inhibitors |
| 05/11/2006 | WO2006048228A1 Method for the generation of virus producing cell lines and cell lines |
| 05/11/2006 | WO2006048215A1 Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof |
| 05/11/2006 | WO2006048025A1 Structural nucleic acid guided chemical synthesis |
| 05/11/2006 | WO2006047842A2 Modified nucleosides for rna interference |
| 05/11/2006 | WO2006026451A3 Targeted expression of apoptosis-inducing genes for disease treatment |
| 05/11/2006 | WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof |
| 05/11/2006 | WO2006012627A3 Actrii receptor polypeptides, methods and compositions |
| 05/11/2006 | WO2005123141A3 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 05/11/2006 | WO2005118816A3 Protein exhibiting triglyceride hydrolase activity |
| 05/11/2006 | WO2005118647A3 M13 virus major coat protein variants for c-terminal and bi-terminal display of a heterologous protein |
| 05/11/2006 | WO2005117994A3 Bmp pathway methods and compositions |
| 05/11/2006 | WO2005116245B1 CDNA production from cells after laser microdissection |
| 05/11/2006 | WO2005116228A3 Fermentative production of fine chemicals |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005108422A3 Ammonium/ammonia transporter |
| 05/11/2006 | WO2005105836A3 Methods and materials for improving plant drought tolerance |